We are live on
!
Find out more
MC
Miles Capital Portfolio holdings
AUM
$92.8M
Turnover
35.94%
1-Year Est. Return
4.29%
This Fund
S&P 500
This Quarter
Est. Return
+2.59%
1 Year Est. Return
-4.29%
3 Year Est. Return
+15.37%
5 Year Est. Return
+31.98%
10 Year Est. Return
–
AUM
$147M
AUM Growth
-$2.09M
(-1.4%)
Cap. Flow
-$5.35M
Cap. Flow
% of AUM
-3.64%
Top 10 Holdings %
Top 10 Hldgs %
43.35%
Holding
215
New
61
Increased
50
Reduced
62
Closed
32
Avg Time Held
0.8
years
Top 10 Avg Time Held
1.3
years
Top 20 Avg Time Held
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$8.4M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$1.13M |
| 3 |
Gilead Sciences
GILD
|
+$1.11M |
| 4 |
CERN
Cerner Corp
CERN
|
+$1.06M |
| 5 |
GE Aerospace
GE
|
+$1.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$12.8M |
| 2 |
Exelon
EXC
|
+$1.08M |
| 3 |
Sysco
SYY
|
+$1.04M |
| 4 |
Cisco
CSCO
|
+$1.03M |
| 5 |
Procter & Gamble
PG
|
+$1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 40.88% |
| 2 | Financials | 11.57% |
| 3 | Healthcare | 8.61% |
| 4 | Technology | 8.21% |
| 5 | Industrials | 6.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Equifax
EFX
$17.7B
| $326K | 0.22% |
2,536
-1,880
| -43% | -$228K |
2015 Q3
3 quarters
|
|
102
Thermo Fisher Scientific
TMO
$249B
| $324K | 0.22% |
2,195
-1,629
| -43% | -$240K |
2015 Q2
4 quarters
|
|
103
Verisk Analytics
VRSK
$23.5B
| $324K | 0.22% |
3,994
-3,181
| -44% | -$250K |
2015 Q4
2 quarters
|
|
|
EBSB
104
DELISTED
Meridian Bancorp, Inc.
EBSB
| $319K | 0.22% |
21,585
+319
| +2% | +$4.64K |
2015 Q3
3 quarters
|
|
105
DELISTED
Perficient Inc
PRFT
| $314K | 0.21% |
15,470
+224
| +1% | +$4.64K |
2015 Q4
2 quarters
|
|
106
DELISTED
Du Pont De Nemours E I
DD
| $313K | 0.21% |
4,836
-11,059
| -70% | -$726K |
2014 Q4
6 quarters
|
|
|
ESRX
107
DELISTED
Express Scripts Holding Company
ESRX
| $312K | 0.21% |
4,112
-3,086
| -43% | -$227K |
2015 Q3
3 quarters
|
|
108
Adobe
ADBE
$93.7B
| $309K | 0.21% |
3,226
-2,375
| -42% | -$228K |
2015 Q3
3 quarters
|
|
|
ABMD
109
DELISTED
Abiomed Inc
ABMD
| $309K | 0.21% |
2,823
+156
| +6% | +$15.5K |
2016 Q1
1 quarter
|
|
110
Merit Medical Systems
MMSI
$5.2B
| $298K | 0.2% |
+15,027
| New | +$289K |
2016 Q2
0 quarters
|
|
|
TMX
111
DELISTED
Terminix Global Holdings, Inc.
TMX
| $298K | 0.2% |
11,169
+161
| +1% | +$4.09K |
2015 Q4
2 quarters
|
|
112
Ligand Pharmaceuticals
LGND
$5.88B
| $297K | 0.2% |
3,998
+233
| +6% | +$17.3K |
2016 Q1
1 quarter
|
|
|
CORE
113
DELISTED
Core Mark Holding Co., Inc.
CORE
| $297K | 0.2% |
+6,334
| New | +$268K |
2016 Q2
0 quarters
|
|
114
Medtronic
MDT
$121B
| $295K | 0.2% |
3,403
-2,469
| -42% | -$200K |
2014 Q3
7 quarters
|
|
115
Sensient Technologies
SXT
$5.65B
| $295K | 0.2% |
4,149
+61
| +1% | +$4.13K |
2016 Q1
1 quarter
|
|
116
DELISTED
Assertio
ASRT
| $292K | 0.2% |
+248
| New | +$271K |
2016 Q2
0 quarters
|
|
117
CVS Health
CVS
$116B
| $292K | 0.2% |
3,055
-2,136
| -41% | -$213K |
2014 Q4
6 quarters
|
|
118
Bank of New York Mellon
BNY
$93.4B
| $291K | 0.2% |
7,482
-5,466
| -42% | -$217K |
2015 Q3
3 quarters
|
|
119
Hanover Insurance
THG
$7.88B
| $291K | 0.2% |
3,442
+49
| +1% | +$4.22K |
2015 Q4
2 quarters
|
|
120
iShares Core S&P Mid-Cap ETF
IJH
$121B
| $290K | 0.2% |
9,695
| – | – |
2014 Q1
9 quarters
|
|
121
Prestige Consumer Healthcare
PBH
$2.29B
| $290K | 0.2% |
5,238
+76
| +1% | +$4.19K |
2015 Q4
2 quarters
|
|
122
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $289K | 0.2% |
+14,757
| New | +$295K |
2016 Q2
0 quarters
|
|
|
NGHC
123
DELISTED
National General Holdings Corp
NGHC
| $289K | 0.2% |
+13,485
| New | +$289K |
2016 Q2
0 quarters
|
|
124
PayPal
PYPL
$48B
| $288K | 0.2% |
7,876
-5,855
| -43% | -$224K |
2015 Q4
2 quarters
|
|
125
Fair Isaac
FICO
$15.5B
| $285K | 0.19% |
2,525
+37
| +1% | +$4.02K |
2016 Q1
1 quarter
|
|
Similar funds
PCM
BP
CFW
SCM
BBA
PCM
FAM
SI
Miles Capital's Q2 2016 Portfolio in Review
As of Q2 2016, Miles Capital held 215 positions worth $147M, down 1.4% from $149M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Miles Capital withdrew a net $5.35M in Q2 2016, closing 32 positions and reducing 62 holdings. Its most notable exit was Baxter International, an estimated $913K position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, down from 42% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Miles Capital opened a new position in Berkshire Hathaway Class B worth $1.15M.
- Miles Capital's largest Q2 2016 buy was Berkshire Hathaway Class B: 7,908 shares worth $1.15M.
- Miles Capital added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2016, an estimated $8.4M increase.
- Miles Capital's biggest Q2 2016 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $12.8M.
- Miles Capital fully exited Baxter International in Q2 2016, selling an estimated $913K.
- Miles Capital's ten largest holdings make up 43% of its $147M portfolio in Q2 2016.
- Miles Capital opened 61 new positions and closed 32 in Q2 2016.
- Miles Capital's portfolio value fell 1.4% quarter-over-quarter to $147M.
Based on Miles Capital's 13F filing for Q2 2016, filed 11 Aug 2016.